Professor Dr. med. Andreas Schnitzbauer
Professor Dr. med. Andreas Schnitzbauer
Universitätsklinikum Frankfurt, Goethe Universität Frankfurt am Main
Verified email at
Cited by
Cited by
Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for …
AA Schnitzbauer, SA Lang, H Goessmann, S Nadalin, J Baumgart, ...
Annals of surgery 255 (3), 405-414, 2012
Early survival and safety of ALPPS: first report of the International ALPPS Registry
E Schadde, V Ardiles, R Robles-Campos, M Malago, M Machado, ...
Annals of surgery 260 (5), 829-838, 2014
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study
D Nepogodiev, JC Glasbey, E Li, OM Omar, JFF Simoes, TEF Abbott, ...
The Lancet, 2020
Sirolimus use in liver transplant recipients with hepatocellular carcinoma: a randomized, multicenter, open-label phase 3 trial
EK Geissler, AA Schnitzbauer, C Zülke, PE Lamby, A Proneth, C Duvoux, ...
Transplantation 100 (1), 116, 2016
Prediction of mortality after ALPPS Stage-1
E Schadde, DA Raptis, AA Schnitzbauer, V Ardiles, C Tschuor, M Lesurtel, ...
Annals of surgery 262 (5), 780-786, 2015
Immediate and long‐term impact of the COVID‐19 pandemic on delivery of surgical services
K Søreide, J Hallet, JB Matthews, AA Schnitzbauer, PD Line, PBS Lai, ...
The British journal of surgery, 2020
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for …
AA Schnitzbauer, C Zuelke, C Graeb, J Rochon, I Bilbao, P Burra, ...
BMC cancer 10 (1), 1-8, 2010
A randomized, controlled study to assess the conversion from calcineurin‐inhibitors to everolimus after liver transplantation—PROTECT
L Fischer, J Klempnauer, S Beckebaum, HJ Metselaar, P Neuhaus, ...
American Journal of Transplantation 12 (7), 1855-1865, 2012
Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes
J Weigert, M Neumeier, J Wanninger, S Bauer, S Farkas, MN Scherer, ...
The Journal of Clinical Endocrinology & Metabolism 95 (3), 1404-1411, 2010
Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study
F Saliba, P De Simone, F Nevens, L De Carlis, HJ Metselaar, ...
American journal of transplantation 13 (7), 1734-1745, 2013
Systematic review and meta-analysis of feasibility, safety, and efficacy of a novel procedure: associating liver partition and portal vein ligation for staged hepatectomy
E Schadde, AA Schnitzbauer, C Tschuor, DA Raptis, WO Bechstein, ...
Annals of surgical oncology 22 (9), 3109-3120, 2015
Patient blood management is associated with a substantial reduction of red blood cell utilization and safe for patient's outcome
P Meybohm, E Herrmann, AU Steinbicker, M Wittmann, M Gruenewald, ...
Annals of surgery 264 (2), 203-211, 2016
Calcineurin inhibitor minimization protocols in liver transplantation
SA Farkas, AA Schnitzbauer, G Kirchner, A Obed, B Banas, HJ Schlitt
Transplant international 22 (1), 49-60, 2009
Bile duct damage after cold storage of deceased donor livers predicts biliary complications after liver transplantation
SM Brunner, H Junger, P Ruemmele, AA Schnitzbauer, A Doenecke, ...
Journal of Hepatology 58 (6), 1133-1139, 2013
Fatal pneumonia caused by Panton-Valentine Leucocidine-positive methicillin-resistant Staphylococcus aureus (PVL-MRSA) transmitted from a healthy donor in living-donor liver …
A Obed, AA Schnitzbauer, T Bein, N Lehn, HJ Linde, HJ Schlitt
Transplantation 81 (1), 121-124, 2006
Small-interference RNA-mediated knock-down of aldehyde oxidase 1 in 3T3-L1 cells impairs adipogenesis and adiponectin release
J Weigert, M Neumeier, S Bauer, W Mages, AA Schnitzbauer, A Obed, ...
FEBS letters 582 (19), 2965-2972, 2008
Safety and feasibility of third-party multipotent adult progenitor cells for immunomodulation therapy after liver transplantation--a phase I study (MISOT-I)
FC Popp, B Fillenberg, E Eggenhofer, P Renner, J Dillmann, V Benseler, ...
Journal of translational medicine 9 (1), 124, 2011
Pre‐existent portal vein thrombosis in liver transplantation: influence of pre‐operative disease severity
A Doenecke, TY Tsui, C Zuelke, MN Scherer, AA Schnitzbauer, HJ Schlitt, ...
Clinical transplantation 24 (1), 48-55, 2010
Is resection or transplantation the ideal treatment in patients with hepatocellular carcinoma in cirrhosis if both are possible? A systematic review and metaanalysis
A Proneth, F Zeman, HJ Schlitt, AA Schnitzbauer
Annals of surgical oncology 21 (9), 3096-3107, 2014
Serum ferritin concentration and transferrin saturation before liver transplantation predict decreased long‐term recipient survival
TJ Weismüller, GI Kirchner, MN Scherer, AA Negm, AA Schnitzbauer, ...
Hepatology 54 (6), 2114-2124, 2011
The system can't perform the operation now. Try again later.
Articles 1–20